v3.26.1
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2023 $ 7 $ 277,965 $ (354,928) $ 143 $ (76,813)
Balance (in Shares) at Dec. 31, 2023 49,065,361        
Exercise of common stock options 532 532
Exercise of common stock options (in Shares) 398,883        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 669,059        
Exercise of common stock warrants $ 1 1
Exercise of common stock warrants (in Shares) 5,343,616        
Issuance of common stock for exchange of debt 2,220 2,220
Issuance of common stock for exchange of debt (in Shares) 1,500,000        
Issuance of common stock 7,144 7,144
Issuance of common stock (in Shares) 2,918,837        
Modification of Warrant Agreement   7,306     7,306
Offering costs of reverse recapitalization   (1,396)     (1,396)
Stock-based compensation 3,067 3,067
Stock-based compensation (in Shares)        
Issuance of common stock warrants 1,400 1,400
Issuance of common stock warrants (in Shares)        
Issuance of common stock warrants for services 9,179 9,179
Issuance of common stock warrants for services (in Shares)        
Issuance of common stock upon conversion of SAFEs $ 6 6,244 6,250
Issuance of common stock upon conversion of SAFEs (in Shares) 13,888,889        
Net income loss     (56,451)   (56,451)
Foreign currency translation adjustment       22 22
Balance at Dec. 29, 2024 $ 14 313,661 (411,379) 165 (97,539)
Balance (in Shares) at Dec. 29, 2024 73,784,645        
Exercise of common stock options 57 57
Exercise of common stock options (in Shares) 43,793        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 192,398        
Exercise of common stock warrants 60 60
Exercise of common stock warrants (in Shares) 6,000,000        
Stock-based compensation 469 469
Net income loss     4,812   4,812
Balance at Mar. 30, 2025 $ 14 314,247 (406,567) 165 (92,141)
Balance (in Shares) at Mar. 30, 2025 80,020,836        
Balance at Dec. 29, 2024 $ 14 313,661 (411,379) 165 (97,539)
Balance (in Shares) at Dec. 29, 2024 73,784,645        
Conversion of 7.0% senior unsecured convertible notes for shares of common stock $ 1 14,684 14,685
Conversion of 7.0% senior unsecured convertible notes for shares of common stock (in Shares) 8,600,580        
Issuance of common stock as consideration for acquisition of businesses $ 1 22,192 22,193
Issuance of common stock as consideration for acquisition of businesses (in Shares) 13,577,258        
Exercise of common stock options 480 480
Exercise of common stock options (in Shares) 730,265        
Taxes paid related to net share settlements of equity awards   (1,898)     (1,898)
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 4,632,211        
Exercise of common stock warrants 60 60
Exercise of common stock warrants (in Shares) 6,000,000        
Issuance of common stock   6,741 6,741
Issuance of common stock (in Shares) 4,010,000        
Stock-based compensation 10,488 10,488
Stock-based compensation (in Shares)        
Net income loss     (45,354)   (45,354)
Balance at Dec. 28, 2025 $ 16 366,408 (456,733) 165 (90,144)
Balance (in Shares) at Dec. 28, 2025 111,334,959        
Conversion of 7.0% senior unsecured convertible notes for shares of common stock 2,646 2,646
Conversion of 7.0% senior unsecured convertible notes for shares of common stock (in Shares) 1,608,769        
Issuance of common stock as consideration for acquisition of businesses 3,333 3,333
Issuance of common stock as consideration for acquisition of businesses (in Shares) 1,805,705        
Non-cash issuance of shares of common stock for debt commitment fees, capitalized as debt issuance costs 333 333
Non-cash issuance of shares of common stock for debt commitment fees, capitalized as debt issuance costs (in Shares) 175,000        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 863,030        
Issuance of common stock 6,991 6,991
Issuance of common stock (in Shares) 4,560,000        
Stock-based compensation 1,605 1,605
Sunder deferred consideration 8,533 8,533
Net income loss     5,250   5,250
Balance at Mar. 29, 2026 $ 16 $ 389,849 $ (451,483) $ 165 $ (61,453)
Balance (in Shares) at Mar. 29, 2026 120,347,463